CAMOVID: Multicenter, randomized 1: 1, double-blind, placebo-controlled two-arm trial to evaluate the efficacy and safety of camostat mesylate for the treatment of SARS-CoV-2 infection in adult ambulatory patients (trial CAMOVID)
- Funded by Ministre des Solidarités et de la Santé (France)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Ministre des Solidarités et de la Santé (France)Principal Investigator
David BoutboulResearch Location
FranceLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Clinical trial (unspecified trial phase)
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Randomized Controlled Trial
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified